3. Observation Indicators and Statistical Methods
congenital heart disease, wheezing, pulmonary wheezing, mental disorders, immunodeficiency and respiratory failure
VIRUS, DISEASE, HEARING IMPAIRMENTS, ADVERSE REACTION, REGRESSION, COLD
The baseline data of 98 children with AB who are diagnosed and treated in our hospital from January 2021 to August 2022 are analyzed, and they are randomly divided into a combined group and a single group. The inclusion criteria are as follows: (1) meet the diagnostic criteria of AB disease, (2) high degree of treatment cooperation, (3) receive glucocorticoid aerosol therapy, (4) complete clinical data, and (5) the family members of the children are informed about the study and sign the consent form. The exclusion criteria are as follows: (1) children with congenital heart disease, (2) children with immunodeficiency and respiratory failure, (3) children with mental disorders and hearing impairments, and (4) unable to participate in this study throughout.A single group receives clinical interventions as follows: (1) the AB intervention group is set up by professional medical staff to evaluate various indicators of children with AB based on multiparty literature and their own clinical experience. (2) The nursing team members regularly organize knowledge training to consolidate and deepen the content of clinical nursing paths and related treatment methods. At the same time, the team members need to introduce the content and functions of clinical nursing to the families of the children in detail, so as (3) to strengthen the family members' compliance with treatment, provide the corresponding drug care to the child in a timely manner, and, at the same time, inform the family of the child about the knowledge and principles of the drug, instruct the family to pay attention to the relevant precautions, and deal with the adverse reaction in a timely manner and (4) to actively carry out health education and psychological intervention for the families of children, introduce disease-related knowledge, and strengthen family members' understanding of the disease and its intervention effects, thereby reducing family members' negative emotions such as tension and fear and relieving psychological pressure.The combined group is guided by the combined use of knowledge, belief, and action theory based on a single group intervention. The specific contents are as follows. (1) Understand: collect baseline data such as age, gender, and birth status. At the same time, family-related baseline data (occupation, education level, age, etc.) are collected to preliminarily estimate the family's cognition of the disease and understand its exact needs. Relevant knowledge such as disease etiology, clinical signs, intervention measures, and treatment background is determined. At the same time, an on-site demonstration operation is set up, and the medical staff comments on the operation of the family members, encourages the family members to communicate with each other, and solves the family members' questions. (2) Trust: help family members deal with the problems encountered during the intervention, always pay attention to the psychological state of family members, and provide timely guidance to ensure that family members treat the disease with a positive and correct attitude and build confidence in treatment. (3) Action: instruct family members to pay more attention to their children's diet. The diet structure needs to be healthy and scientific, eating more foods rich in vitamins and proteins that are easy to digest and avoiding cold, irritating, and sweet foods. In addition, the ward should be ventilated in time, maintaining a suitable humidity, ensuring the bed supplies should be replaced in time to reduce virus invasion, and paying attention to scientific medication.Observation indicators are as follows:
The clinical efficacy of the research subjects is analyzed. (1) Significantly effective: 2 days after the intervention, the wheezing and pulmonary wheezing are completely relieved. (2) Effective: 7 days after the intervention, the wheezing and pulmonary wheezing are significantly relieved. (3) Ineffective: Seven days after the intervention, the clinical symptoms of the children did not change or even worsened compared with those before the intervention. Treatment effective rate is equal to (marked number + effective number)/total × 100%Analyze the pulmonary function level of the research subjects, including forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), and the percentage of FEV1 in FVC (FEV1/FVC%)Univariate analysis of the influencing factors of poor prognosis in children with ABBinary logistic regression analysis of risk factors affecting the prognosis of children with ABThe data are unified and entered into SPSS 26.0 software for processing. The measurement data are expressed as mean ± standard deviation (